Silencing of Prrx1b suppresses cellular proliferation, migration, invasion and epithelial-mesenchymal transition in triple-negative breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Silencing of Prrx1b suppresses cellular proliferation, migration, invasion and epithelial-mesenchymal transition in triple-negative breast cancer

Published:2016-03-29 Issue:9 Volume:20 Page:1640-1650
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J. Cell. Mol. Med.

Author:

Lv Zhi-Dong¹,Yang Zhao-Chuan²,Liu Xiang-Ping³,Jin Li-Ying⁴,Dong Qian⁵,Qu Hui-Li¹,Li Fu-Nian¹,Kong Bin¹,Sun Jiao¹,Zhao Jiao-Jiao¹,Wang Hai-Bo¹

Affiliation:

1. Center of Diagnosis and Treatment of Breast Disease; The Affiliated Hospital of Qingdao University; Qingdao China

2. Departments of Child Health Care; The Affiliated Hospital of Qingdao University; Qingdao China

3. Central Laboratory of Molecular Biology; The Affiliated Hospital of Qingdao University; Qingdao China

4. Cerebrovascular Disease Research Institute; The Affiliated Hospital of Qingdao University; Qingdao China

5. Departments of Pediatric Surgery; The Affiliated Hospital of Qingdao University; Qingdao China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Shandong Province

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jcmm.12856/fullpdf

Reference29 articles.

1. Antitumor activity of Cetuximab in combination with Ixabepilone on triple negative breast cancer stem cells;Tanei;Breast Cancer Res,2016

2. SHP2 acts both upstream and downstream of multiple receptor tyrosine kinases to promote basal-like and triple-negative breast cancer;Matalkah;Breast Cancer Res,2016

3. Non-specific blocking of miR-17-5p guide strand in triple negative breast cancer cells by amplifying passenger strand activity;Jin;PLoS ONE,2015

4. Potent efficacy of metronomic topotecan and pazopanib combination therapy in preclinical models of primary or late stage metastatic triple-negative breast cancer;Di Desidero;Oncotarget,2015

5. MicroRNA-26a promotes anoikis in human hepatocellular carcinoma cells by targeting alpha5 integrin;Zhang;Oncotarget,2015

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retraction: Silencing of Prrx1b suppresses cellular proliferation, migration, invasion and epithelial–mesenchymal transition in triple‐negative breast cancer;Journal of Cellular and Molecular Medicine;2024-04

2. Retraction Note to: Mesothelial cells differentiate into fibroblast-like cells under the scirrhous gastric cancer microenvironment and promote peritoneal carcinomatosis in vitro and in vivo;Molecular and Cellular Biochemistry;2023-12-01

3. RETRACTION: Silencing of Prrx2 Inhibits the Invasion and Metastasis of Breast Cancer both In Vitro and In Vivo by Reversing Epithelial- Mesenchymal Transition (Retraction of Vol 42, Pg 1847, 2017);CELL PHYSIOL BIOCHEM;2023

4. PRRX2 predicts poor survival prognosis, and promotes malignant phenotype of lung adenocarcinoma via transcriptional activates PSMD1;Translational Oncology;2023-01

5. An Overview of Epithelial-to-Mesenchymal Transition and Mesenchymal-to-Epithelial Transition in Canine Tumors: How Far Have We Come?;Veterinary Sciences;2022-12-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3